Evidence map›Paper›PMID 38147185›Full record

Trial reportSports medicine (Auckland, N.Z.)2024

Acute Effects of Ad Libitum Use of Commercially Available Cannabis Products on the Subjective Experience of Aerobic Exercise: A Crossover Study.

Laurel P Gibson, Gregory R Giordano, L Cinnamon Bidwell, Kent E Hutchison, Angela D Bryan

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Sports medicine (Auckland, N.Z.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Laurel P GibsonDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA. laurel.gibson@colorado.edu.ORCID 0000-0002-6684-2126
Gregory R GiordanoDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
L Cinnamon BidwellDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Kent E HutchisonDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Angela D BryanDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
University of Colorado Boulder · USUniversity of Colorado Anschutz Medical Campus · US

Funding

National Science Foundation DGE 1650115University of Colorado Boulder Center for Research and Education Addressing Cannabis and Health Interdisciplinary Research Scholar Award
6 · The paper itself

Abstract

objectiveThe present study aimed to examine the acute effects of legal-market cannabis on regular cannabis users' subjective responses to exercise in a controlled laboratory environment.

backgroundGiven the stereotype that cannabis is associated with extreme sedentary behavior, there are concerns that cannabis legalization may exacerbate the US physical inactivity epidemic. However, despite these concerns, recent years have seen considerable public interest in the use of cannabis concurrently with exercise (e.g., running).

methodsThe present study compared participants' experiences of exercise without cannabis to their experiences of exercise after acute ad libitum use of one of two commercially available cannabis flower products: a Δ9-tetrahydrocannabinol-dominant or a cannabidiol-dominant product. Participants (N = 42) were regular cannabis users between the ages of 21 and 39 years (mean = 30.81 years, standard deviation = 4.72 years).

resultsAlthough participants reported a more positive affect (p < 0.001), enjoyment (p < 0.001), and runner's high symptoms (p < 0.001) during their cannabis (vs non-cannabis) exercise appointment, they also reported more exertion (p = 0.04). Pain levels were very low and did not differ between appointments (p = 0.45). Effects appeared to depend, in part, on cannabinoid content; there was a larger difference in enjoyment (p = 0.02), and a smaller difference in exertion (p = 0.02), between the cannabis and non-cannabis exercise appointments among participants in the cannabidiol (vs Δ9-tetrahydrocannabinol) condition.

conclusionsTo our knowledge, this is the first study to investigate the acute effects of commercially available cannabis on subjective responses to exercise in a laboratory environment. Our findings suggest that, among regular cannabis users who use cannabis in combination with exercise, cannabis use prior to exercise may lead to increases in both positive and negative aspects of the subjective exercise experience. Research using diverse samples, exercise modalities, and methodologies (e.g., placebo-controlled trials) is needed to establish the generalizability of these findings.

Indexed as

CannabidiolCannabisCross-Over StudiesDronabinolExerciseAdultAffectFemaleHumansMalePhysical ExertionPleasureRunningYoung AdultCannabidiolDronabinol

Identifiers

PMID38147185
OpenAlexW4390228695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.